Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
1992-10-2
|
| pubmed:abstractText |
The bone metastases of a malignant, non-secreting paraganglioma were treated with [131I]metaiodobenzylguanidine (131I-MIBG) over a 10-year period. Initial treatment (131I-MIBG: 9.6 GBq) resulted in a decrease in the number of bone metastases from 16 to 2. At three years, a relapse with primary tumor regrowth and liver metastasis was again treated with 131I-MIBG (22.2 GBq). A decrease in the number of bone metastases and MIBG uptake was again observed.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0368-3249
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
35
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
313-4
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:1823844-3-Iodobenzylguanidine,
pubmed-meshheading:1823844-Adult,
pubmed-meshheading:1823844-Antineoplastic Agents,
pubmed-meshheading:1823844-Bone Neoplasms,
pubmed-meshheading:1823844-Combined Modality Therapy,
pubmed-meshheading:1823844-Female,
pubmed-meshheading:1823844-Humans,
pubmed-meshheading:1823844-Iodine Radioisotopes,
pubmed-meshheading:1823844-Iodobenzenes,
pubmed-meshheading:1823844-Paraganglioma
|
| pubmed:articleTitle |
[131I]metaiodobenzylguanidine treatment of a malignant paraganglioma.
|
| pubmed:affiliation |
Service de Médecine Nucléaire, Hôpital Bretonneau, Tours, France.
|
| pubmed:publicationType |
Journal Article,
Case Reports
|